Why global pharma is betting on India’s next-generation CDMOs
Hindustan Times ·
For years, India’s appeal as a contract development and manufacturing destination rested largely on cost competitiveness.
Why global pharma is betting on India’s next-generation CDMOs
For years, India’s appeal as a contract development and manufacturing destination rested largely on cost competitiveness.
1 sources · 1 articles · updated 2026-11-08 14:47 UTC · general